M2™ Platform Recognized for the Significant Innovation that it Provides
to the Pre-Clinical Imaging Marketplace
TORONTO, Canada, SHOHAM, Israel, Jan. 2, 2012 /CNW/ - The Scientist today unveiled the Top 10 Innovations of 2011 and selected Aspect Imaging's M2™ compact high-performance MRI imaging system as one
the winners of this award. The Scientist invited members of the life science community to submit descriptions of
exciting tools that made an impact in research this year and asked a
panel of expert judges to evaluate the technologies. "The 2011 winners
represent an exceptional combination of ingenuity and technical
advances," said Mary Beth Aberlin, Editor-in-Chief of The Scientist.
"We are thrilled that The Scientist and their expert panel selected our M2 imaging platform as one of the
'Top 10 Innovations' in life science," says Uri Rapoport, Aspect
Imaging's Founder and CEO. "With the rapid adoption of our technology
and the growing use of our M2 MRI system globally to quantify
biomarkers in vivo, we are most proud of the new insights that our customers in research
and drug development are deriving by using our M2 platform. This award
is further recognition as to the value MRI and most specifically - -
the M2 high-performance compact MRI system - - is providing to the life
scientist to quantify the expression of disease, to monitor disease
progression and to assess therapeutic efficacy and response in vivo".
Full details on The Scientist and its announcement of the winners of the "Top 10 Innovations of 2011"
can be found at http://the-scientist.com/2012/01/01/top-ten-innovations-2011/.
About Aspect Imaging:
Aspect Imaging (www.aspectimaging.com) is the world's leader in high-performance compact MRI imaging systems
for preclinical, clinical and advanced industrial applications. In
preclinical research, Aspect's M2™ platform and suite of products
enables academic researchers and pharmaceutical companies to harness
the power and insights of MRI but without the cost, complexity and
technical burden of traditional MRI systems. With Aspect's integrated
and simple-to-use platform, researchers can derive deep insights into
their biological questions quickly, easily and cost-effectively - - and
all with the push of a button. As the system has no fringe magnetic
field, the M2 can be placed anywhere in a working lab including at a
scientist's benchtop. The M2™ platform is used by leading institutions
for a broad range of in vivo, ex vivo and in vitro applications including high-resolution 3D anatomical, molecular, functional and
multi-modality imaging. The Aspect high-performance MRI system is used
to quantify the expression of disease, to monitor disease progression
and to assess therapeutic efficacy and response.
SOURCE Aspect Imaging
For further information: